BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25253772)

  • 1. Disruption of hSWI/SNF complexes in T cells by WAS mutations distinguishes X-linked thrombocytopenia from Wiskott-Aldrich syndrome.
    Sarkar K; Sadhukhan S; Han SS; Vyas YM
    Blood; 2014 Nov; 124(23):3409-19. PubMed ID: 25253772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wiskott-Aldrich syndrome/X-linked thrombocytopenia in China: Clinical characteristic and genotype-phenotype correlation.
    Liu DW; Zhang ZY; Zhao Q; Jiang LP; Liu W; Tu WW; Song WX; Zhao XD
    Pediatr Blood Cancer; 2015 Sep; 62(9):1601-8. PubMed ID: 25931402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. R-loops cause genomic instability in T helper lymphocytes from patients with Wiskott-Aldrich syndrome.
    Sarkar K; Han SS; Wen KK; Ochs HD; Dupré L; Seidman MM; Vyas YM
    J Allergy Clin Immunol; 2018 Jul; 142(1):219-234. PubMed ID: 29248492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear role of WASp in the pathogenesis of dysregulated TH1 immunity in human Wiskott-Aldrich syndrome.
    Taylor MD; Sadhukhan S; Kottangada P; Ramgopal A; Sarkar K; D'Silva S; Selvakumar A; Candotti F; Vyas YM
    Sci Transl Med; 2010 Jun; 2(37):37ra44. PubMed ID: 20574068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of 28 novel mutations in the Wiskott-Aldrich syndrome and X-linked thrombocytopenia based on multiplex PCR.
    Proust A; Guillet B; Picard C; de Saint Basile G; Pondarré C; Tamary H; Dreyfus M; Tchernia G; Fischer A; Delaunay J
    Blood Cells Mol Dis; 2007; 39(1):102-6. PubMed ID: 17400488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical aspects and genetic analysis of taiwanese patients with wiskott-Aldrich syndrome protein mutation: the first identification of x-linked thrombocytopenia in the chinese with novel mutations.
    Lee WI; Huang JL; Jaing TH; Wu KH; Chien YH; Chang KW
    J Clin Immunol; 2010 Jul; 30(4):593-601. PubMed ID: 20232122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Report of clinical presentations and two novel mutations in patients with Wiskott-Aldrich syndrome/X-linked Thrombocytopenia.
    Udomkittivorakul N; Wattanasirichaigoon D; Manuyakorn W; Pongphitcha P; Khongkraparn A; Tunlayadechanont P; Sirachainan N
    Platelets; 2022 Jul; 33(5):792-796. PubMed ID: 34705590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and genetic analysis of 2 rare cases of Wiskott-Aldrich syndrome from Chinese minorities: Two case reports.
    Liu H; Wang Y; Li Y; Tao L; Zhang Y; He X; Zhou Y; Liu X; Wang Y; Li L
    Medicine (Baltimore); 2021 Apr; 100(16):e25527. PubMed ID: 33879693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, Laboratory Features and Clinical Courses of Patients with Wiskott Aldrich Syndrome and X-linked Thrombocytopenia-A single center study.
    Bildik HN; Cagdas D; Ozturk Kura A; Oskay Halacli S; Sanal O; Tezcan I
    Immunol Invest; 2022 Jul; 51(5):1272-1283. PubMed ID: 34098853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations of the WASP gene in 10 Japanese patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.
    Itoh S; Nonoyama S; Morio T; Imai K; Okawa H; Ochs HD; Shimadzu M; Yata J
    Int J Hematol; 2000 Jan; 71(1):79-83. PubMed ID: 10729999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A peptide derived from the Wiskott-Aldrich syndrome (WAS) protein-interacting protein (WIP) restores WAS protein level and actin cytoskeleton reorganization in lymphocytes from patients with WAS mutations that disrupt WIP binding.
    Massaad MJ; Ramesh N; Le Bras S; Giliani S; Notarangelo LD; Al-Herz W; Notarangelo LD; Geha RS
    J Allergy Clin Immunol; 2011 Apr; 127(4):998-1005.e1-2. PubMed ID: 21376381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent low platelet counts hampering diagnosis of X-linked thrombocytopenia in children: report of two unrelated cases and a novel mutation in the gene coding for the Wiskott-Aldrich syndrome protein.
    Medina SS; Siqueira LH; Colella MP; Yamaguti-Hayakawa GG; Duarte BKL; Dos Santos Vilela MM; Ozelo MC
    BMC Pediatr; 2017 Jun; 17(1):151. PubMed ID: 28641574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of the Wiskott-Aldrich Syndrome Protein affect protein expression and dictate the clinical phenotypes.
    Ochs HD
    Immunol Res; 2009; 44(1-3):84-8. PubMed ID: 19082760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative control: what's WASp doing in the nucleus?
    Teitell MA
    Sci Transl Med; 2010 Jun; 2(37):37ps31. PubMed ID: 20574067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monozygotic twin pair showing discordant phenotype for X-linked thrombocytopenia and Wiskott-Aldrich syndrome: a role for epigenetics?
    Buchbinder D; Nadeau K; Nugent D
    J Clin Immunol; 2011 Oct; 31(5):773-7. PubMed ID: 21710275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-linked thrombocytopenia causing mutations in WASP (L46P and A47D) impair T cell chemotaxis.
    Jain N; Tan JH; Feng S; George B; Thanabalu T
    J Biomed Sci; 2014 Sep; 21(1):91. PubMed ID: 25200405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two novel mutations identified in the Wiskott-Aldrich syndrome protein gene cause Wiskott-Aldrich syndrome and thrombocytopenia.
    Andreu N; Matamoros N; Escudero A; Fillat C
    Int J Mol Med; 2007 May; 19(5):777-82. PubMed ID: 17390083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation spectrum in patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia: identification of twelve different mutations in the WASP gene.
    Schwartz M; Békássy A; Donnér M; Hertel T; Hreidarson S; Kerndrup G; Stormorken H; Stokland T; Tranebjaerg L; Orstavik KH; Skovby F
    Thromb Haemost; 1996 Apr; 75(4):546-50. PubMed ID: 8743175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of WASP mutations in 10 Australian families with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.
    Bourne HC; Weston S; Prasad M; Edkins E; Benson EM
    Pathology; 2004 Jun; 36(3):262-4. PubMed ID: 15203732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired NK-cell migration in WAS/XLT patients: role of Cdc42/WASp pathway in the control of chemokine-induced beta2 integrin high-affinity state.
    Stabile H; Carlino C; Mazza C; Giliani S; Morrone S; Notarangelo LD; Notarangelo LD; Santoni A; Gismondi A
    Blood; 2010 Apr; 115(14):2818-26. PubMed ID: 20130240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.